Cita APA

Arriola Aperribay, E., Castro, J. d., García Campelo, R., Bernárdez, B., Bernabé, R., Bruna, J., . . . Felip, E. (2024). Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer.

Citación estilo Chicago

Arriola Aperribay, Edurne, et al. Expert Consensus On the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer. 2024.

Cita MLA

Arriola Aperribay, Edurne, et al. Expert Consensus On the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer. 2024.